Graviton Bioscience
1 known investors
Find your way into Graviton Bioscience
Sign up to find every way you can get introduced to Graviton Bioscience
- Your email: who you already know at Graviton Bioscience, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Graviton Bioscience team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Graviton develops immunomodulatory therapies for patients with fibrotic, autoimmune, and central nervous system diseases. The company targets multiple molecular pathways to reduce disease burden and restore biological balance.
Founders & leadership
SW

Samuel WaksalFounder & CEO
Investors · 1
Pontifax Venture Capitallisted by Pontifax Venture CapitalHerzeliya · $6.3M – $128M
How we know: Pontifax Venture Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Graviton Bioscience do?
- Graviton develops immunomodulatory therapies for patients with fibrotic, autoimmune, and central nervous system diseases. The company targets multiple molecular pathways to reduce disease burden and restore biological balance.
- Who founded Graviton Bioscience?
- Graviton Bioscience was founded by Samuel Waksal.
- Who are Graviton Bioscience's investors?
- Graviton Bioscience's investors include Pontifax Venture Capital.
